Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | FNTA | P49354 | 4/20 | 0.42 |
| ▸ | FNTB | P49356 | 4/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38594 | 1.00 | ALDH1A1 (0.54) | ALDH1A1KDM4EL3MBTL1RNPEPLMNA | |
| SCHEMBL28781190 | 1.00 | ALDH1A1 (0.54) | ALDH1A1KDM4EL3MBTL1RNPEPLMNA | |
| SCHEMBL38595 | 1.00 | ALDH1A1 (0.54) | ALDH1A1KDM4EL3MBTL1RNPEPLMNA | |
| SCHEMBL28222352 | 0.98 | ALDH1A1 (0.52) | ALDH1A1KDM4EL3MBTL1RNPEPLMNA | |
| SCHEMBL16149858 | 0.98 | ALDH1A1 (0.52) | ALDH1A1KDM4EL3MBTL1RNPEPLMNA | |
| SCHEMBL16149859 | 0.98 | ALDH1A1 (0.52) | ALDH1A1KDM4EL3MBTL1RNPEPLMNA | |
| SCHEMBL28222355 | 0.98 | ALDH1A1 (0.52) | ALDH1A1KDM4EL3MBTL1RNPEPLMNA | |
| Fluoride SCHEMBL29174742 | 0.98 | ALDH1A1 (0.52) | ALDH1A1KDM4EL3MBTL1RNPEPLMNA | |
| SCHEMBL16150979 | 0.96 | ALDH1A1 (0.51) | ALDH1A1KDM4EL3MBTL1RNPEPLMNA | |
| SCHEMBL28269388 | 0.96 | ALDH1A1 (0.51) | ALDH1A1KDM4EL3MBTL1RNPEPLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119090106-A | Real-time ship navigation route planning method based on augmented reality | 广州市上赛电子科技有限公司 | 2024-12-06 | — | — | CN | claimed |
| US-20240280590-A1 | COMPOSITIONS AND METHODS FOR FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY BIOMARKER DETECTION | UNIVERSITY OF WASHINGTON (US) | 2024-08-22 | — | — | US | claimed |
| CN-110857315-A | Polypeptide medicine and derivative for treating tumor and use method thereof | 许洋 | 2020-03-03 | — | — | CN | claimed |
| CN-122029189-A | Anti-SARS-CoV-2 spike (S) antibodies and their use in treatment COVID-19 | 诺瓦瓦克斯股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-12587161-B2 | Higher order lamb wave acoustic devices with complementarily-oriented piezoelectric layers | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2026-03-24 | — | — | US | disclosed |
| CN-121606556-A | Treatment of fragile X syndrome with cannabidiol | 和谐生物科学管理有限公司 | 2026-03-06 | — | — | CN | disclosed |
| EP-3928072-B1 | CORE BODY TEMPERATURE SENSOR AND METHOD FOR THE MANUFACTURING THEREOF | TNO (NL) | 2026-02-11 | — | — | EP | disclosed |
| US-20260027137-A1 | TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL | HARMONY BIOSCIENCES MANAGEMENT, INC. (US) | 2026-01-29 | — | — | US | disclosed |
| EP-4611738-A1 | COMPOSITIONS COMPRISING MDMA AND METHODS OF USING SAME | Lykos Therapeutics, Inc. (US) | 2025-09-10 | — | — | EP | disclosed |
| US-20250177322-A1 | TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL | HARMONY BIOSCIENCES MANAGEMENT, INC. (US) | 2025-06-05 | — | — | US | disclosed |
| CN-119090106-B | Real-time ship navigation route planning method based on augmented reality | 广州市上赛电子科技有限公司 | 2025-05-30 | — | — | CN | disclosed |
| EP-3965730-A1 | ANTIBIOTIC ELUTING POLY (ESTER UREA) FILMS FOR INFECTION CONTROL OF IMPLANTABLE MEDICAL DEVICES | The University of Akron (US) | 2022-03-16 | — | — | EP | disclosed |
| US-20220073908-A1 | METHODS OF PRODUCING HIGH DIVERSITY PEPTIDE LIBRARIES AND PROMOTING PROTEIN FOLDING | Repertoire Immune Medicines, Inc. | 2022-03-10 | — | — | US | disclosed |
| CN-110857315-A | Polypeptide medicine and derivative for treating tumor and use method thereof | 许洋 | 2020-03-03 | — | — | CN | disclosed |
| WO-2015164289-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS | CIDARA THERAPEUTICS, INC. (US) | 2015-10-29 | — | — | WO | disclosed |
| US-20110020914-A1 | METHODS FOR ENHANCING GROWTH OF ORGANISMS IN AN AQUEOUS GROWTH MEDIUM | NOVUS INTERNATIONAL INC (US) | 2011-01-27 | — | — | US | disclosed |
| WO-2010126794-A1 | METHODS FOR INCREASING GROWTH AND YIELD OF PLANTS WITH METHIONINE COMPOUNDS | NOVUS INTERNATIONAL INC. (US) | 2010-11-04 | — | — | WO | disclosed |
| US-20070231377-A1 | COMPOSITIONS FOR PROMOTING HAIR GROWTH | NOVUS INTERNATIONAL INC. (US) | 2007-10-04 | — | — | US | disclosed |
| EP-0304021-B1 | ACYLAMINO ACID RACEMASE, PRODUCTION AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 1993-04-28 | — | — | EP | disclosed |
| EP-0304021-A2 | Acylamino acid racemase, Production and use thereof | Takeda Chemical Industries, Ltd. (JP) | 1989-02-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12587161-B2 | Higher order lamb wave acoustic devices with complementarily-oriented piezoelectric layers | PIEZO1, GJB2, GJA1 | ALDH1A1 4222/4885KDM4E 1260/4885L3MBTL1 42/4885 |
| US-20260027137-A1 | TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL | MECP2, FOS, FOSB | ALDH1A1 4670/4885KDM4E 59/4885L3MBTL1 1311/4885 |
| US-20070231377-A1 | COMPOSITIONS FOR PROMOTING HAIR GROWTH | FGF1, MTR, HGF | ALDH1A1 2239/4885KDM4E 1133/4885L3MBTL1 987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.